Delcath (DCTH) 2026 Earnings Outlook: What Investors Need
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Investigate common budgeting blockers that prevent savings and identify actionable changes. This intro guides you toward steady, growing savings.
27,247 articlesBiotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Dream Finders' unsolicited cash offer values Beazer at about $704 million, sparking a public contest as U.S. homebuil...
New York City honors Jack Kirby with a street-name dedication on a Lower East Side block, recognizing the immigrant a...
The (feam) 2026 earnings call offers more than numbers. It reveals management’s strategy, how FEAM is navigating cost...
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...
An FDA leadership shakeup deepens as Tracy Hoeg publicly says she was fired, prompting questions about regulatory dir...
As investors await a potential new federal reserve chair, analysts say the policy path could lift small-cap stocks. T...
Keysight's Q2 2026 earnings transcript sheds light on demand, margins, and strategic priorities. This guide decodes t...
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
An attacker minted $13.5 million in unbacked StablR tokens via a multisig exploit, triggering a rapid EURR and USDR d...
Investors chased space-focused stocks higher on SpaceX IPO speculation, lifting Spacemobile 20%, Planet Labs 15%, and...
Meta unveils a groundbreaking $145 billion AI infrastructure plan for 2026, signaling a bold pivot from social media ...